1,642 result(s) found
Wall Street Analysts Think Builders FirstSource (BLDR) Is a Good Investment: Is It?
https://www.zacks.com/stock/news/2244757/wall-street-analysts-think-builders-firstsource-bldr-is-a-good-investment-is-it?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2244757
Mar 22, 2024 - According to the average brokerage recommendation (ABR), one should invest in Builders FirstSource (BLDR). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
0
Panasonic (PCRFY) Is Considered a Good Investment by Brokers: Is That True?
https://www.zacks.com/stock/news/2244756/panasonic-pcrfy-is-considered-a-good-investment-by-brokers-is-that-true?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2244756
Mar 22, 2024 - According to the average brokerage recommendation (ABR), one should invest in Panasonic (PCRFY). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
0
Good Days for the Market, Employment & More
https://www.zacks.com/stock/news/2244119/good-days-for-the-market-employment-more?cid=CS-ZC-FT-ahead_of_wall_street-2244119
Mar 21, 2024 - Jobless Claims, Philly Fed and Current Account Balance are all better than analysts had projected. Pre-markets are up again.
0
Repsol SA (REPYY) Now Trades Above Golden Cross: Time to Buy?
https://www.zacks.com/stock/news/2244077/repsol-sa-repyy-now-trades-above-golden-cross-time-to-buy?cid=CS-ZC-FT-tale_of_the_tape|golden_crossover-2244077
Mar 21, 2024 - Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
0
'3 Body Problem' Is a Tech-Heavy Head Trip
https://www.wired.com/story/gadget-lab-podcast-637/
Mar 21, 2024 - This week, we discuss how the new (very good) Netflix series 3 Body Problem fits into the sci-fi pantheon.
0
Trevi Therapeutics, Inc. (TRVI) Q4 2023 Earnings Call Transcript
https://seekingalpha.com/article/4679489-trevi-therapeutics-inc-trvi-q4-2023-earnings-call-transcript?source=feed_sector_transcripts
Mar 20, 2024 - Trevi Therapeutics, Inc. (NASDAQ:NASDAQ:TRVI) Q4 2023 Earnings Conference Call March 20, 2024 4:30 PM ETCompany ParticipantsJennifer Good - President &...
0
PCN: Good Bond CEF With Fully-Covered Distribution, But Huge Premium Is Problematic
https://seekingalpha.com/article/4679459-pcn-good-bond-cef-with-fully-covered-distribution-but-huge-premium-problematic?source=feed_tag_etf_portfolio_strategy
Mar 20, 2024 - The PIMCO Corporate & Income Strategy Fund offers a competitive yield, but its underperformance and high premium raise concerns. Click for my PCN update.
0
FNGS: Too Much Of A Good Thing Adds To Downside Risk
https://seekingalpha.com/article/4679456-fngs-etn-too-much-good-thing-adds-downside-risk?source=feed_tag_etf_portfolio_strategy
Mar 20, 2024 - The MicroSectors FANG+ ETN is a tech-focused ETF that has seen impressive returns but faced challenges in market downturns. Learn more on FNGS here.
0
Chevron Stock Has 29% Upside, According to 1 Wall Street Analyst
https://www.fool.com/investing/2024/03/20/chevron-stock-upside-wall-street-analyst/?source=iedfolrf0000001
Mar 20, 2024 - Despite uncertainty around the Hess deal, the oil major looks like a good value.
0
Aurora granted Australian approval for cannabis production facilities
https://seekingalpha.com/news/4081616-aurora-granted-australian-approval-for-cannabis-production-facilities?source=feed_sector_healthcare
Mar 20, 2024 - Aurora Cannabis (ACB) said it has been granted Good Manufacturing Practice certification by Australian regulators for two Canadian production facilities. Read more here.
0